Advertisement
U.S. Markets open in 8 hrs 27 mins

Nykode Therapeutics AS (NYKD.OL)

Oslo - Oslo Delayed Price. Currency in NOK
4.2920+0.0180 (+0.42%)
At close: 04:25PM CET
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
6,147
12,902
7,168
33,963
215,000
Operating Expense
64,999
70,984
60,324
44,738
36,738
Operating Income
-58,852
-58,082
-53,156
-10,775
178,262
Net Non Operating Interest Income Expense
7,929
8,722
3,309
166
-60
Pretax Income
-47,806
-44,086
-50,983
-11,118
180,905
Tax Provision
-9,892
-8,932
-8,240
-1,704
31,130
Net Income Common Stockholders
-37,915
-35,154
-42,743
-9,414
149,774
Diluted NI Available to Com Stockholders
-37,915
-35,154
-42,743
-9,414
149,774
Basic EPS
-0.14
-0.12
-0.15
-0.03
0.54
Diluted EPS
-0.14
-0.12
-0.15
-0.03
0.51
Basic Average Shares
305,532
300,520
290,119
286,345
279,643
Diluted Average Shares
305,532
300,520
290,119
286,345
296,145
Total Operating Income as Reported
-58,852
-58,082
-53,156
-10,775
178,265
Rent Expense Supplemental
-
933
753
665
362
Total Expenses
64,999
70,984
60,324
44,738
36,738
Net Income from Continuing & Discontinued Operation
-37,915
-35,154
-42,743
-9,414
149,774
Normalized Income
-37,915
-35,154
-42,829
-9,511
149,719
Interest Income
8,145
8,946
3,687
270
198
Interest Expense
216
224
241
130
46
Net Interest Income
7,929
8,722
3,309
166
-60
EBIT
-47,590
-43,862
-50,742
-10,988
180,951
EBITDA
-45,337
-41,740
-48,928
-10,253
181,255
Reconciled Depreciation
2,253
2,122
1,814
734
304
Net Income from Continuing Operation Net Minority Interest
-37,915
-35,154
-42,743
-9,414
149,774
Total Unusual Items Excluding Goodwill
0
0
102
115
66
Total Unusual Items
0
0
102
115
66
Normalized EBITDA
-45,337
-41,740
-49,030
-10,368
181,189
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
16.4855
17.6255
11.3572